Le Lézard
Classified in: Health, Science and technology
Subject: AWD

Acceliant Wins Stevie at 2018 American Business Awards


SANTA CLARA, California and BANGALORE, India, June 14, 2018 /PRNewswire/ --

Acceliant, a global leader in e-clinical data management solutions, today announced having won a Stevie Award at the 16th Annual American Business Awards, a premier business awards program in the US. Acceliant was honored with a Bronze Stevie Award in the 'New Product or Service of the Year - Software - Healthcare Technology Solution' category.

For close to two decades now, Acceliant has been helping companies in the clinical trials segment streamline their processes, monetize costs, better manage risks, shorten product development lifecycles, and increase operational efficiencies. The company recently unveiled a new version of its eClinical Trial Management Solution (eClinical Suite), Acceliant 7.0.2. This version, powered by Study Data Tabulation Module (SDTM), has new upgrades on randomization, multi-trial management and an improved mobile app user interface.

Speaking on receiving the recognition, Prashant Bhavaraju - Chief Marketing Officer at Acceliant, said, "We're delighted about Acceliant being named the 'Product of the Year' by the American Business Awards. Our eClinical Suite version 7.0.2 offers a comprehensive set of solutions facilitating faster, smoother, and efficient clinical research. The Stevie Award from industry experts further reinforces the value we bring to our clients."

About the Stevie® Awards 

Stevie Awards are conferred in seven programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, The American Business Awards®, The International Business Awards®, the Stevie Awards for Women in Business, the Stevie Awards for Great Employers, and the Stevie Awards for Sales & Customer Service. Stevie Awards competitions receive more than 10,000 entries each year from organizations in more than 60 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com.

About Acceliant 

Acceliant provides real-time, integrated clinical trial solutions for life sciences, CROs and pharma tools and expertise to take intelligent and smarter decisions. Its eClinical Suite allows users to build studies, design electronic case report forms (eCRFs), capture data through multiple sources (EDC), capture data directly from patients (ePRO), and manage other clinical data management functions.

Media Contact:
Prashant Bhavaraju
Chief Marketing Officer
Acceliant
[email protected]
+1-408-387-5800

https://www.acceliant.com 


SOURCE Acceliant


These press releases may also interest you

at 06:50
Merck , known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved KEYTRUDA, Merck's anti-PD-1 therapy, in combination with platinum-containing chemotherapy as neoadjuvant treatment, then...

at 06:31
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual...

at 06:30
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular...

at 06:30
The collagen water market is booming thanks to the growing popularity of health and beauty products. Consumers are more interested in skincare and healthy eating, which is driving manufacturers to create collagen-infused drinks and cosmetics. A new...

at 06:30
Viavi Solutions Inc. (VIAVI)  today announced it has participated in the 2024 RIC Forum, March 26-28, in Dallas, Texas. The company contributed its TeraVM RIC Test and TM500 Network Tester to multiple demonstrations, building on collaborations at MWC...

at 06:30
Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively...



News published on and distributed by: